首页 > 最新文献

Medicinski arhiv最新文献

英文 中文
The Correlation of Positive and Negative Symptoms (PANSS Scores) in Patients with Schizophrenia According to Gender. 精神分裂症患者阳性和阴性症状(PANSS评分)的性别相关性
Q2 Medicine Pub Date : 2023-04-01 DOI: 10.5455/medarh.2023.77.123-126
Gorana Sulejmanpasic, Amra Memic-Serdarevic, Selma Sabanagic-Hajric, Nermina Bajramagic

Background: Schizophrenia is chronic and debilitating psychiatric disorder, characterized by a constellation of clinical signs and symptoms that are categorized into distinct positive, negative, disorganization and cognitive symptom domains. The outcome of the disease is better in female patients compared to male patients who have a higher risk of rehospitalization and twice as long duration of hospital treatment. In male patients with schizophrenia an earlier onset of the disease, negative symptoms and a more severe clinical picture are noted, with a less promising therapeutic response to neuroleptics. The onset of negative symptoms is more variable.

Objective: The aim of the study was to determine the correlation of positive and negative symptoms (PANSS scores) in patients with schizophrenia according to gender.

Methods: The sample included 40 subjects with schizophrenia (21 males; 19 females). The study was conducted at the Department of Psychiatry Clinical Center University of Sarajevo.

Results: All male subjects have a PANSS negative symptoms score of 17 or higher, while all female subjects have a PANSS negative symptoms score of less than 17. While the difference in the variances is not statistically significant, the results show that the difference in the average values of the PANSS symptom score between male and female subjects is statistically significant for both positive and negative symptoms (p=0.026).

Conclusion: Diminished sociality, emotional responsiveness, and drive during childhood have been reported in a substantial minority of patients with schizophrenia. This aspect of the illness may account for the low level of emotional expression and neuromotor dysfunction in infants who subsequently have schizophrenia. In other patients, the negative symptoms first occur after the onset of psychosis.

背景:精神分裂症是一种慢性衰弱性精神疾病,其特征是一系列临床体征和症状,可分为明显的阳性、阴性、紊乱和认知症状域。与男性患者相比,女性患者的预后更好,男性患者再次住院的风险更高,住院治疗时间是男性患者的两倍。男性精神分裂症患者发病较早,出现阴性症状和较严重的临床症状,对抗精神病药物的治疗效果较差。阴性症状的发作更加多变。目的:研究精神分裂症患者阳性和阴性症状(PANSS评分)在性别上的相关性。方法:40例精神分裂症患者(男性21例;19岁女性)。这项研究是在萨拉热窝大学精神病学临床中心进行的。结果:所有男性受试者的PANSS阴性症状评分均在17分及以上,所有女性受试者的PANSS阴性症状评分均在17分以下。虽然方差差异无统计学意义,但结果显示,阳性和阴性症状的PANSS症状评分均值在男女被试之间的差异均有统计学意义(p=0.026)。结论:据报道,少数精神分裂症患者在童年时期社交能力、情绪反应能力和驱动力下降。这方面的疾病可以解释低水平的情绪表达和神经运动功能障碍的婴儿随后患有精神分裂症。在其他患者中,阴性症状在精神病发作后首次出现。
{"title":"The Correlation of Positive and Negative Symptoms (PANSS Scores) in Patients with Schizophrenia According to Gender.","authors":"Gorana Sulejmanpasic,&nbsp;Amra Memic-Serdarevic,&nbsp;Selma Sabanagic-Hajric,&nbsp;Nermina Bajramagic","doi":"10.5455/medarh.2023.77.123-126","DOIUrl":"https://doi.org/10.5455/medarh.2023.77.123-126","url":null,"abstract":"<p><strong>Background: </strong>Schizophrenia is chronic and debilitating psychiatric disorder, characterized by a constellation of clinical signs and symptoms that are categorized into distinct positive, negative, disorganization and cognitive symptom domains. The outcome of the disease is better in female patients compared to male patients who have a higher risk of rehospitalization and twice as long duration of hospital treatment. In male patients with schizophrenia an earlier onset of the disease, negative symptoms and a more severe clinical picture are noted, with a less promising therapeutic response to neuroleptics. The onset of negative symptoms is more variable.</p><p><strong>Objective: </strong>The aim of the study was to determine the correlation of positive and negative symptoms (PANSS scores) in patients with schizophrenia according to gender.</p><p><strong>Methods: </strong>The sample included 40 subjects with schizophrenia (21 males; 19 females). The study was conducted at the Department of Psychiatry Clinical Center University of Sarajevo.</p><p><strong>Results: </strong>All male subjects have a PANSS negative symptoms score of 17 or higher, while all female subjects have a PANSS negative symptoms score of less than 17. While the difference in the variances is not statistically significant, the results show that the difference in the average values of the PANSS symptom score between male and female subjects is statistically significant for both positive and negative symptoms (p=0.026).</p><p><strong>Conclusion: </strong>Diminished sociality, emotional responsiveness, and drive during childhood have been reported in a substantial minority of patients with schizophrenia. This aspect of the illness may account for the low level of emotional expression and neuromotor dysfunction in infants who subsequently have schizophrenia. In other patients, the negative symptoms first occur after the onset of psychosis.</p>","PeriodicalId":18421,"journal":{"name":"Medicinski arhiv","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e1/1b/medarch-77-123.PMC10227848.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9564328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effectiveness of Eplerenone vs Spironolactone on Left Ventricular Systolic Function, Hospitalization and Cardiovascular Death in Patients With Chronic Heart Failure-HFrEF. 埃普利酮与螺内酯对慢性心力衰竭患者左心室收缩功能、住院和心血管死亡的影响
Q2 Medicine Pub Date : 2023-04-01 DOI: 10.5455/medarh.2023.77.105-111
Nabil Naser, Azra Durak-Nalbantic, Nirvana Sabanovic-Bajramovic, Alen Karic

Background: Heart failure remains one of the most prevalent clinical syndromes associated with significant morbidity and mortality. According to current guidelines, the prescription of a MRA is recommended to reduce the risk of HF hospitalization and death in all patients with symptomatic heart failure and no contraindications for this therapy.

Objective: The aim of our study was to determine the efficacy of eplerenone vs. spironolactone on left ventricular systolic function by measuring left ventricle ejection fraction (LVEF) in patients with chronic heart failure, especially their effect on preventing hospitalization, reducing mortality, and improving clinical status among patients with chronic HF.

Methods: From June 2021 to June 2022, the study was a randomized, prospective clinical trial single blind study. A total of 142 patients of chronic heart failure with reduced ejection fraction were selected by random sampling. Each patient was randomly allocated into either of the two groups and was continued receiving treatment with either spironolactone (Spiron-HF group) or eplerenone (Epler-HF group). Patients in Epler-HF group were compared with an arm of the same size and matched by age and gender patients in Spiron-HF group for management of chronic HFrEF. Each patient was evaluated clinically, biochemically, and echocardiographically at the beginning of treatment (baseline) after 6 months and at the end of 12th month. Echocardiography was performed to find out change in left ventricular systolic function.

Results: After 12 months of treatment, significant improvement of left ventricular ejection fraction was observed in eplerenone treated arm (37.9 ± 3.8 ± 4.6 in Spiron-HF group versus 40.1 ± 5.7 in Epler-HF group; P < 0.05). A significant reduction in left ventricular end-systolic volume (6.3 ± 2.5ml in Spiron-HF versus 17.8± 4.4ml in Epler-HF group; P < 0.05) and left ventricular systolic diameter volume (2.7 ± 0.5ml in Spiron-HF versus 6.7 ± 0.2ml in Epler-HF group; P < 0.05), occurred after 12 months of treatment. Left ventricular global longitudinal strain (LV GLS) was significantly improved in Epler-HF group compared with Spiron-HF group (0.6 ± 0.4 versus 3.4 ± 0.9; P < 0.05). There were no significant differences observed in reduction of left ventricular end-diastolic volume (2.2 ± 0.5 ml versus 4.7 ± 1.1ml; P =0.103) and left ventricular diastolic diameter (1.2 ± 0.6 versus 1.7 ± 0.3; P=0.082) in both arms. The effects of both MRA agents spironolactone and eplerenone on the primary composite outcome, each of the individual mortality and hospital admission outcomes are shown in Figure 1 and 2. Patients of the Epler-HF group showed statistically significant lower cardiovascular mortality (HR 0.53; 95% CI 0.34-0.82; p= 0.007) and all-cause mortality (HR 0.64; 95% CI 0.44-0.93; p= 0.022) than patients of the Spiron-HF group. The statistical analysis di

背景:心力衰竭仍然是最常见的临床综合征之一,与显著的发病率和死亡率相关。根据目前的指南,建议所有有症状的心力衰竭患者使用MRA处方来降低HF住院和死亡的风险,并且该疗法没有禁忌症。目的:我们的研究旨在通过测量慢性心力衰竭患者的左心室射血分数(LVEF)来确定依普利酮与螺内酯对左心室收缩功能的影响,特别是它们在预防慢性心衰患者住院、降低死亡率和改善临床状况方面的作用。方法:2021年6月至2022年6月,该研究是一项随机、前瞻性临床试验的单盲研究。随机抽取142例射血分数降低的慢性心力衰竭患者。每个患者被随机分配到两组中的任何一组,并继续接受螺内酯(Spiron HF组)或依普利酮(Epler HF组)的治疗。将Epler HF组的患者与Spiron HF组中相同大小、按年龄和性别匹配的手臂进行比较,以治疗慢性HFrEF。在6个月后的治疗开始(基线)和12个月底,对每位患者进行临床、生化和超声心动图评估。超声心动图检查左心室收缩功能的变化。结果:治疗12个月后,依普利酮治疗组的左心室射血分数显著改善(Spiron HF组为37.9±3.8±4.6,Epler HF组为40.1±5.7;P<0.05)(Spiron HF组为2.7±0.5ml,Epler HF组为6.7±0.2ml;P<0.05)。与Spiron HF组相比,Epler HF组的左心室整体纵向应变(LV GLS)显著改善(0.6±0.4对3.4±0.9;P<0.05)双臂。MRA药物螺内酯和依普利酮对主要复合结果、每个个体死亡率和住院结果的影响如图1和图2所示。Epler HF组患者的心血管死亡率(HR 0.53;95%CI 0.34-0.82;p=0.007)和全因死亡率(HR 0.64;95%CI 0.44-0.93;p=0.022)均低于Spiron HF组患者。统计分析没有显示Epler-HF和Spiron HF研究组在主要复合结果风险方面的统计学显著差异;HF引起的心血管死亡或住院(依普利酮与螺内酯的危险比=0.95;95%置信区间(CI)0.73-1.27;p=0.675)。结论:在治疗HFrEF中,与螺内酯相比,我们的研究表明依普利酮对心脏重塑参数以及降低心血管死亡率和全因死亡率有良好的效果。依普利酮能够有效阻断盐皮质激素受体,同时最大限度地减少副作用,显著降低住院和心血管死亡风险,这证实了其在治疗慢性HFrEF患者中的关键作用。
{"title":"The Effectiveness of Eplerenone vs Spironolactone on Left Ventricular Systolic Function, Hospitalization and Cardiovascular Death in Patients With Chronic Heart Failure-HFrEF.","authors":"Nabil Naser,&nbsp;Azra Durak-Nalbantic,&nbsp;Nirvana Sabanovic-Bajramovic,&nbsp;Alen Karic","doi":"10.5455/medarh.2023.77.105-111","DOIUrl":"10.5455/medarh.2023.77.105-111","url":null,"abstract":"<p><strong>Background: </strong>Heart failure remains one of the most prevalent clinical syndromes associated with significant morbidity and mortality. According to current guidelines, the prescription of a MRA is recommended to reduce the risk of HF hospitalization and death in all patients with symptomatic heart failure and no contraindications for this therapy.</p><p><strong>Objective: </strong>The aim of our study was to determine the efficacy of eplerenone vs. spironolactone on left ventricular systolic function by measuring left ventricle ejection fraction (LVEF) in patients with chronic heart failure, especially their effect on preventing hospitalization, reducing mortality, and improving clinical status among patients with chronic HF.</p><p><strong>Methods: </strong>From June 2021 to June 2022, the study was a randomized, prospective clinical trial single blind study. A total of 142 patients of chronic heart failure with reduced ejection fraction were selected by random sampling. Each patient was randomly allocated into either of the two groups and was continued receiving treatment with either spironolactone (Spiron-HF group) or eplerenone (Epler-HF group). Patients in Epler-HF group were compared with an arm of the same size and matched by age and gender patients in Spiron-HF group for management of chronic HFrEF. Each patient was evaluated clinically, biochemically, and echocardiographically at the beginning of treatment (baseline) after 6 months and at the end of 12th month. Echocardiography was performed to find out change in left ventricular systolic function.</p><p><strong>Results: </strong>After 12 months of treatment, significant improvement of left ventricular ejection fraction was observed in eplerenone treated arm (37.9 ± 3.8 ± 4.6 in Spiron-HF group versus 40.1 ± 5.7 in Epler-HF group; P < 0.05). A significant reduction in left ventricular end-systolic volume (6.3 ± 2.5ml in Spiron-HF versus 17.8± 4.4ml in Epler-HF group; P < 0.05) and left ventricular systolic diameter volume (2.7 ± 0.5ml in Spiron-HF versus 6.7 ± 0.2ml in Epler-HF group; P < 0.05), occurred after 12 months of treatment. Left ventricular global longitudinal strain (LV GLS) was significantly improved in Epler-HF group compared with Spiron-HF group (0.6 ± 0.4 versus 3.4 ± 0.9; P < 0.05). There were no significant differences observed in reduction of left ventricular end-diastolic volume (2.2 ± 0.5 ml versus 4.7 ± 1.1ml; P =0.103) and left ventricular diastolic diameter (1.2 ± 0.6 versus 1.7 ± 0.3; P=0.082) in both arms. The effects of both MRA agents spironolactone and eplerenone on the primary composite outcome, each of the individual mortality and hospital admission outcomes are shown in Figure 1 and 2. Patients of the Epler-HF group showed statistically significant lower cardiovascular mortality (HR 0.53; 95% CI 0.34-0.82; p= 0.007) and all-cause mortality (HR 0.64; 95% CI 0.44-0.93; p= 0.022) than patients of the Spiron-HF group. The statistical analysis di","PeriodicalId":18421,"journal":{"name":"Medicinski arhiv","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/bc/dc/medarch-77-105.PMC10227849.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9571262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Obturator Nerve Block for Transurethral Resection of Bladder Tumors. 闭孔神经阻滞在经尿道膀胱肿瘤切除术中的应用。
Q2 Medicine Pub Date : 2023-04-01 DOI: 10.5455/medarh.2023.77.118-122
Aleksandra Gavrilovska-Brzanov, Skender Seidi, Sotir Stavridis, Ognen Ivanovski, Josif Janchulev, Viktor Stankov, Marija Jovanovski Srceva, Biljana Kuzmanovska

Background: Bladder tumors are identified and treated using a surgical procedure called as transurethral resection of bladder tumors (TUR-BT). During TUR-BT resection, stimulation of the obturator nerve may cause violent adductor muscle spasms. The "obturator reflex," as this disorder is known, generally causes the legs to move inadvertently (leg jerking). Since this condition can cause several complications, it is preferable to avoid it.

Objective: In this study, we investigated the effectiveness of spinal anesthesia combined with obturator nerve block or general anesthetic without muscle relaxant in preventing adductor muscle spasm during TUR-BT procedures.

Methods: Forty consecutive patients were enrolled in a prospective observational evaluation and divided into two groups. Patients in Group I underwent spinal anesthesia along with an obturator nerve block, while those in Group II underwent general anesthesia without a neuromuscular relaxant. The following details were recorded: time for obturator block performance, the severity of the motor blockade, the length of the procedure in both groups because a probable adductor spasm might make it more difficult. The level of the surgeon's pleasure was noted throughout the surgery. Additionally, the patient's satisfaction and any issues that may have arisen were documented (the incidence of vascular puncture, hematoma, nerve damage, and visceral injury was noted).

Results: Block performance time in Group I was 4.8±0.5 minutes, whereas it was 5.0±0.3 minutes in Group II. The ease of access for the two groups was the same. Group I demonstrated increased patient and surgeon satisfaction with a general anesthesia without neuromuscular relaxants and an obturatorius nerve block. Mean surgical time did not differ between the groups.There were no complications in either group.

Conclusion: During such operations, routine use of ONB in combination with spinal anaesthetic or general anesthetic without a neuromuscular blocker can enhance oncological outcomes for patients, reduce complication rates, and extend the period of time spent living without disease.

背景:膀胱肿瘤的识别和治疗采用经尿道膀胱肿瘤切除术(turt - bt)。在turt - bt切除过程中,对闭孔神经的刺激可引起剧烈的内收肌痉挛。这种疾病被称为“闭孔反射”,通常会导致腿部无意识地移动(腿抽搐)。由于这种情况会引起一些并发症,最好避免它。目的:在本研究中,我们探讨脊髓麻醉联合闭孔神经阻滞或全身麻醉不加肌肉松弛剂在turt - bt手术中预防内收肌痉挛的有效性。方法:连续40例患者进行前瞻性观察性评价,分为两组。第一组患者行脊髓麻醉并封闭神经阻滞,而第二组患者行全身麻醉,不使用神经肌肉松弛剂。记录以下细节:闭孔阻滞的时间,运动阻滞的严重程度,两组手术的长度,因为可能的内收肌痉挛会使手术更加困难。外科医生的快乐程度在整个手术过程中被记录下来。此外,记录患者的满意度和可能出现的任何问题(血管穿刺、血肿、神经损伤和内脏损伤的发生率)。结果:ⅰ组阻滞时间为4.8±0.5 min,ⅱ组阻滞时间为5.0±0.3 min。两组的访问难度是相同的。第一组患者和外科医生对全麻不使用神经肌肉松弛剂和闭孔神经阻滞的满意度增加。两组间平均手术时间无差异。两组均无并发症发生。结论:在此类手术中,常规使用ONB联合脊髓麻醉或全身麻醉(不使用神经肌肉阻滞剂)可提高患者的肿瘤预后,减少并发症发生率,延长无病生存时间。
{"title":"Obturator Nerve Block for Transurethral Resection of Bladder Tumors.","authors":"Aleksandra Gavrilovska-Brzanov,&nbsp;Skender Seidi,&nbsp;Sotir Stavridis,&nbsp;Ognen Ivanovski,&nbsp;Josif Janchulev,&nbsp;Viktor Stankov,&nbsp;Marija Jovanovski Srceva,&nbsp;Biljana Kuzmanovska","doi":"10.5455/medarh.2023.77.118-122","DOIUrl":"https://doi.org/10.5455/medarh.2023.77.118-122","url":null,"abstract":"<p><strong>Background: </strong>Bladder tumors are identified and treated using a surgical procedure called as transurethral resection of bladder tumors (TUR-BT). During TUR-BT resection, stimulation of the obturator nerve may cause violent adductor muscle spasms. The \"obturator reflex,\" as this disorder is known, generally causes the legs to move inadvertently (leg jerking). Since this condition can cause several complications, it is preferable to avoid it.</p><p><strong>Objective: </strong>In this study, we investigated the effectiveness of spinal anesthesia combined with obturator nerve block or general anesthetic without muscle relaxant in preventing adductor muscle spasm during TUR-BT procedures.</p><p><strong>Methods: </strong>Forty consecutive patients were enrolled in a prospective observational evaluation and divided into two groups. Patients in Group I underwent spinal anesthesia along with an obturator nerve block, while those in Group II underwent general anesthesia without a neuromuscular relaxant. The following details were recorded: time for obturator block performance, the severity of the motor blockade, the length of the procedure in both groups because a probable adductor spasm might make it more difficult. The level of the surgeon's pleasure was noted throughout the surgery. Additionally, the patient's satisfaction and any issues that may have arisen were documented (the incidence of vascular puncture, hematoma, nerve damage, and visceral injury was noted).</p><p><strong>Results: </strong>Block performance time in Group I was 4.8±0.5 minutes, whereas it was 5.0±0.3 minutes in Group II. The ease of access for the two groups was the same. Group I demonstrated increased patient and surgeon satisfaction with a general anesthesia without neuromuscular relaxants and an obturatorius nerve block. Mean surgical time did not differ between the groups.There were no complications in either group.</p><p><strong>Conclusion: </strong>During such operations, routine use of ONB in combination with spinal anaesthetic or general anesthetic without a neuromuscular blocker can enhance oncological outcomes for patients, reduce complication rates, and extend the period of time spent living without disease.</p>","PeriodicalId":18421,"journal":{"name":"Medicinski arhiv","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/3b/29/medarch-77-118.PMC10227847.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9564325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Myxopapillary Ependymoma-a Case Report of Rare Multicentric Subtype and Literature Review. 黏液乳头状室管膜瘤罕见多中心亚型1例并文献复习。
Q2 Medicine Pub Date : 2023-04-01 DOI: 10.5455/medarh.2023.77.150-154
Faisal R Almatrafi, Abdullah M Aseeri, Mohammad F Alqahtani, Liqa Al Mulla, Saeed Al-Jubran, Majed A AlOmair, Sultan Alsalmi, Rawan Al-Anazi

Background: Myxopapillary ependymoma is a rare type of primary spinal tumor, it is distinctly a slow-growing tumor that originates in the conus medullaris, cauda equina, or film terminals and is rarely identified as a multicentric type. Myxopapillary ependymoma has a unique histological characteristic and is associated with a generally better prognosis.

Objective: We present a case of a rare multicentric myxopapillary ependymoma.

Case presentation: A 28-year-old male with 1-year history of low back pain and 3 months of radiating pain to left lower limb with perianal anesthesia. Magnetic resonance imaging (MRI) exhibited a large intradural intramedullary lesion from the level of the conus medullaris extending to the filum terminals at the level of T12 to L3 with smaller multiple enhancing lesions seen opposite to L4 and L5 level as well as within the exiting nerve roots, at the left side of L1/L2 and L2/L3 and right side of L3/L4 and L5/S1 level. The patient underwent surgical resection with significant improvement in symptoms and no tumor progression on follow up MRI scan.

Conclusion: We hereby present a case of multicentric myxopapillary ependymoma with a literature review of the previous reported cases. We believe that our study will make a significant contribution to the literature and will be of interest to the readership regarding of the rarity of multicentric Myxopapillary ependymoma and it will help in decision making for the proper surgical Intervention on these kinds of cases.

背景:黏液乳头状室管膜瘤是一种罕见的原发性脊柱肿瘤,它是一种生长缓慢的肿瘤,起源于脊髓圆锥、马尾或脊髓膜末梢,很少被认为是多中心型。黏液乳头状室管膜瘤具有独特的组织学特征,通常预后较好。目的:我们报告一例罕见的多中心黏液乳头状室管膜瘤。病例介绍:28岁男性,腰痛1年,左下肢放射痛3个月,肛周麻醉。磁共振成像(MRI)显示从髓圆锥水平延伸至T12至L3水平的髓内硬膜内大病变,在L4和L5水平对面以及在出神经根内,L1/L2和L2/L3左侧和L3/L4和L5/S1水平右侧可见较小的多发强化病变。患者接受手术切除,症状明显改善,随访MRI扫描无肿瘤进展。结论:我们在此报告一例多中心黏液乳头状室管膜瘤,并对以往报道的病例进行文献回顾。我们相信我们的研究将对文献做出重大贡献,并将引起读者对多中心黏液乳头状室管膜瘤罕见性的兴趣,并有助于对此类病例进行适当的手术干预决策。
{"title":"Myxopapillary Ependymoma-a Case Report of Rare Multicentric Subtype and Literature Review.","authors":"Faisal R Almatrafi,&nbsp;Abdullah M Aseeri,&nbsp;Mohammad F Alqahtani,&nbsp;Liqa Al Mulla,&nbsp;Saeed Al-Jubran,&nbsp;Majed A AlOmair,&nbsp;Sultan Alsalmi,&nbsp;Rawan Al-Anazi","doi":"10.5455/medarh.2023.77.150-154","DOIUrl":"https://doi.org/10.5455/medarh.2023.77.150-154","url":null,"abstract":"<p><strong>Background: </strong>Myxopapillary ependymoma is a rare type of primary spinal tumor, it is distinctly a slow-growing tumor that originates in the conus medullaris, cauda equina, or film terminals and is rarely identified as a multicentric type. Myxopapillary ependymoma has a unique histological characteristic and is associated with a generally better prognosis.</p><p><strong>Objective: </strong>We present a case of a rare multicentric myxopapillary ependymoma.</p><p><strong>Case presentation: </strong>A 28-year-old male with 1-year history of low back pain and 3 months of radiating pain to left lower limb with perianal anesthesia. Magnetic resonance imaging (MRI) exhibited a large intradural intramedullary lesion from the level of the conus medullaris extending to the filum terminals at the level of T12 to L3 with smaller multiple enhancing lesions seen opposite to L4 and L5 level as well as within the exiting nerve roots, at the left side of L1/L2 and L2/L3 and right side of L3/L4 and L5/S1 level. The patient underwent surgical resection with significant improvement in symptoms and no tumor progression on follow up MRI scan.</p><p><strong>Conclusion: </strong>We hereby present a case of multicentric myxopapillary ependymoma with a literature review of the previous reported cases. We believe that our study will make a significant contribution to the literature and will be of interest to the readership regarding of the rarity of multicentric Myxopapillary ependymoma and it will help in decision making for the proper surgical Intervention on these kinds of cases.</p>","PeriodicalId":18421,"journal":{"name":"Medicinski arhiv","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1d/e1/medarch-77-150.PMC10227842.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9564330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative Analysis of Transradial and Transfemoral Arterial Approach When Performing Diagnostic Coronary Angiography. 经桡动脉入路与经股动脉入路诊断冠状动脉造影的比较分析。
Q2 Medicine Pub Date : 2023-04-01 DOI: 10.5455/medarh.2023.77.112-117
Alan Jahic, Emir Mujanovic, Mugdim Bajric, Denis Mirsic, Ismar Hasukic

Background: The transfemoral (TF) arterial approach is still the most commonly used approach for performing diagnostic coronary angiography in most centers in the world as well as in Bosnia and Herzegovina. Recently, the transradial (TR) arterial approach has gained more and more supporters among interventional cardiologists.

Objective: The aim of the study was to compare the duration of the procedure, the amount of delivered ionizing radiation, the amount of applied contrast agent, the frequency of procedural complications and patient comfort during coronary angiography performed via TR and TF arterial approach.

Methods: The total sample of 240 respondents was divided into two groups in such a way that the first group consisted of 121 respondents who underwent coronary angiography using TR arterial approach, and the second group consisted of 119 respondents who underwent coronary angiography using TF arterial approach. The Mann-Whitney U test was used to verify the research objective.

Results: The obtained research results showed that the duration of coronary angiography and the amount of radiation was greater when using TR arterial approach compared to TF approach. There is no statistically significant difference in relation to the amount of applied contrast medium and the frequency of complications between the two approaches. Periprocedural and postprocedural comfort was better in patents who underwent TR approach.

Conclusion: The findings of this study show that diagnostic coronary angiography performed via the TR arterial approach is as safe for the patient as diagnostic coronary angiography performed via the TF arterial approach. With both approaches, there is no significant difference in the amount of contrast agent used nor in the frequency of complications. Procedure duration and radiation exposure are shorter when TF arterial approach i used, while patient comfort is better when the TR arterial approach is used.

背景:在世界上大多数中心以及波斯尼亚和黑塞哥维那,经股动脉入路仍然是诊断冠状动脉造影最常用的入路。近年来,经桡动脉入路在介入心脏病专家中得到越来越多的支持。目的:比较经TR和TF动脉入路冠状动脉造影的手术时间、电离辐射量、造影剂用量、手术并发症发生频率和患者舒适度。方法:将240例被调查者分为两组,第一组121例经TR动脉入路行冠状动脉造影,第二组119例经TF动脉入路行冠状动脉造影。采用Mann-Whitney U检验对研究目标进行验证。结果:获得的研究结果显示,与TF入路相比,TR动脉入路冠状动脉造影时间和放射线量更大。两种入路在造影剂用量和并发症发生率方面无统计学差异。经TR入路的患者术中、术后舒适度较好。结论:本研究结果表明,经TR动脉入路行诊断性冠状动脉造影与经TF动脉入路行诊断性冠状动脉造影对患者同样安全。两种方法在造影剂用量和并发症发生频率上均无显著差异。采用TF动脉入路手术时间和放疗时间较短,而采用TR动脉入路患者舒适度较好。
{"title":"Comparative Analysis of Transradial and Transfemoral Arterial Approach When Performing Diagnostic Coronary Angiography.","authors":"Alan Jahic,&nbsp;Emir Mujanovic,&nbsp;Mugdim Bajric,&nbsp;Denis Mirsic,&nbsp;Ismar Hasukic","doi":"10.5455/medarh.2023.77.112-117","DOIUrl":"https://doi.org/10.5455/medarh.2023.77.112-117","url":null,"abstract":"<p><strong>Background: </strong>The transfemoral (TF) arterial approach is still the most commonly used approach for performing diagnostic coronary angiography in most centers in the world as well as in Bosnia and Herzegovina. Recently, the transradial (TR) arterial approach has gained more and more supporters among interventional cardiologists.</p><p><strong>Objective: </strong>The aim of the study was to compare the duration of the procedure, the amount of delivered ionizing radiation, the amount of applied contrast agent, the frequency of procedural complications and patient comfort during coronary angiography performed via TR and TF arterial approach.</p><p><strong>Methods: </strong>The total sample of 240 respondents was divided into two groups in such a way that the first group consisted of 121 respondents who underwent coronary angiography using TR arterial approach, and the second group consisted of 119 respondents who underwent coronary angiography using TF arterial approach. The Mann-Whitney U test was used to verify the research objective.</p><p><strong>Results: </strong>The obtained research results showed that the duration of coronary angiography and the amount of radiation was greater when using TR arterial approach compared to TF approach. There is no statistically significant difference in relation to the amount of applied contrast medium and the frequency of complications between the two approaches. Periprocedural and postprocedural comfort was better in patents who underwent TR approach.</p><p><strong>Conclusion: </strong>The findings of this study show that diagnostic coronary angiography performed via the TR arterial approach is as safe for the patient as diagnostic coronary angiography performed via the TF arterial approach. With both approaches, there is no significant difference in the amount of contrast agent used nor in the frequency of complications. Procedure duration and radiation exposure are shorter when TF arterial approach i used, while patient comfort is better when the TR arterial approach is used.</p>","PeriodicalId":18421,"journal":{"name":"Medicinski arhiv","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2a/86/medarch-77-112.PMC10227836.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9564329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The Importance of Prediabetes Screening in the Prevention of Cardiovascular Disease. 糖尿病前期筛查在预防心血管疾病中的重要性
Q2 Medicine Pub Date : 2023-04-01 DOI: 10.5455/medarh.2023.77.97-104
Vesna Cosic, Jelena Jakab, Marijana Knezevic Pravecek, Blazenka Miskic

Background: Prediabetes is a disordered state of glucose metabolism defined by an elevated blood glucose level that is below the level required for the diagnosis of diabetes. Prediabetes is associated with an increased risk of cardiovascular disease. The onset and progression of macrovascular disease occur during the prediabetes phase. Early diagnosis and screening of prediabetes are essential steps to prevent diabetes and its associated complications.

Objective: To assess the prevalence of prediabetes and undiagnosed diabetes in patients with cardiovascular disease according to the ADA criteria.

Methods: This cross-sectional study included 2968 a high cardiovascular risk patients aged 40 to 75 years admitted to the Department of Internal Medicine. Sociodemographic variables and other relevant medical history information were collected by the researchers during the clinical interview. A fasting blood sample was obtained to determine HbA1c levels and other relevant laboratory findings.

Results: Of the total number of participants, 1496 participants were not diagnosed with diabetes, 485 (32.4%) of them had HbA1c values indicating prediabetes and 158 (10.6%) of them had HbA1c values indicating new diagnosed diabetes. Up to one-third of those with undiagnosed prediabetes had already been diagnosed with cardiovascular complications.

Conclusion: Routine screening of glycemic metabolism could be valuable in identifying high-risk individuals before a cardiovascular event occurs.

背景:前驱糖尿病是一种葡萄糖代谢紊乱状态,其特征是血糖水平升高,低于糖尿病诊断所需的水平。前驱糖尿病与心血管疾病的风险增加有关。大血管疾病的发生和发展发生在糖尿病前期。早期诊断和筛查糖尿病前期是预防糖尿病及其相关并发症的必要步骤。目的:根据ADA标准评估心血管疾病患者糖尿病前期和未确诊糖尿病的患病率。方法:本横断面研究纳入内科收治的40 ~ 75岁心血管高危患者2968例。研究人员在临床访谈中收集了社会人口学变量和其他相关病史信息。获得空腹血液样本以确定HbA1c水平和其他相关实验室结果。结果:在所有参与者中,1496名参与者未被诊断为糖尿病,其中485人(32.4%)的HbA1c值表明糖尿病前期,158人(10.6%)的HbA1c值表明新诊断的糖尿病。多达三分之一的未确诊的前驱糖尿病患者已经被诊断出患有心血管并发症。结论:在心血管事件发生前,血糖代谢的常规筛查对于识别高危人群是有价值的。
{"title":"The Importance of Prediabetes Screening in the Prevention of Cardiovascular Disease.","authors":"Vesna Cosic,&nbsp;Jelena Jakab,&nbsp;Marijana Knezevic Pravecek,&nbsp;Blazenka Miskic","doi":"10.5455/medarh.2023.77.97-104","DOIUrl":"https://doi.org/10.5455/medarh.2023.77.97-104","url":null,"abstract":"<p><strong>Background: </strong>Prediabetes is a disordered state of glucose metabolism defined by an elevated blood glucose level that is below the level required for the diagnosis of diabetes. Prediabetes is associated with an increased risk of cardiovascular disease. The onset and progression of macrovascular disease occur during the prediabetes phase. Early diagnosis and screening of prediabetes are essential steps to prevent diabetes and its associated complications.</p><p><strong>Objective: </strong>To assess the prevalence of prediabetes and undiagnosed diabetes in patients with cardiovascular disease according to the ADA criteria.</p><p><strong>Methods: </strong>This cross-sectional study included 2968 a high cardiovascular risk patients aged 40 to 75 years admitted to the Department of Internal Medicine. Sociodemographic variables and other relevant medical history information were collected by the researchers during the clinical interview. A fasting blood sample was obtained to determine HbA1c levels and other relevant laboratory findings.</p><p><strong>Results: </strong>Of the total number of participants, 1496 participants were not diagnosed with diabetes, 485 (32.4%) of them had HbA1c values indicating prediabetes and 158 (10.6%) of them had HbA1c values indicating new diagnosed diabetes. Up to one-third of those with undiagnosed prediabetes had already been diagnosed with cardiovascular complications.</p><p><strong>Conclusion: </strong>Routine screening of glycemic metabolism could be valuable in identifying high-risk individuals before a cardiovascular event occurs.</p>","PeriodicalId":18421,"journal":{"name":"Medicinski arhiv","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b3/57/medarch-77-97.PMC10227840.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9564327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Herpes Zoster Virus Reactivation in a 16 Year Old Female Post COVID-19 Vaccine. Case report and Review of the Literature. 16岁女性COVID-19疫苗后带状疱疹病毒再激活病例报告及文献回顾。
Q2 Medicine Pub Date : 2023-04-01 DOI: 10.5455/medarh.2023.77.146-149
Sadan Alharbi, Mohammed Alsubaie, Remah Alzayyat, Batool Alattas, Hassan AlAhmadi, Hanoof Alabdullatif

Background: According to WHO, there have been 9205 fatal COVID-19 cases confirmed in Saudi Arabia out of 793,729 cases overall (5). During the development of COVID-19 vaccines, several technologies were used including DNA-based, RNA-based vaccines, non-replicating viral vector vaccines, and inactivated vaccines.

Objective: We present a case of varicella zoster virus reactivation post COVID-19 vaccine in a young medically free 16 years old female and review of the literature using the keywords "Herpes Zoster, "varicella zoster"," shingles", "post COVID-19 vaccine", "Post COVID-19 cutaneous manifestations".

Methods: The search was conducted in Google Scholar, Scopus, PubMed, and Web of Science data bases.

Results: We encountered 241 published studies in regard to post COVID-19 dermatologic manifestations including post COVID-19 vaccine herpes zoster reactivation in the English literature and one case in German. Our case and 4 other reported cases in the literature are patients aged of 20 years old and below.

Conclusion: Varicella zoster virus falls under the family of Herpesviridae, It's characterized by its ability to escape host immune system and remain dormant in ganglionic neurons. Reactivation of the infection will result in herpes zoster manifesting as painful vesicles in a dermatomal distribution. Possible link is the suppression of type-one interferons caused by the mRNA-based vaccine such as COVID-19 vaccines. Yet, potential correlation remains to be demonstrated.

背景:根据世卫组织的数据,沙特阿拉伯共有793,729例COVID-19致命病例,其中9205例确诊(5)。在开发COVID-19疫苗期间,使用了几种技术,包括基于dna的疫苗、基于rna的疫苗、非复制病毒载体疫苗和灭活疫苗。目的:报告1例无医学条件的16岁年轻女性在接种COVID-19疫苗后感染水痘带状疱疹病毒再激活病例,并以“带状疱疹”、“水痘带状疱疹”、“带状疱疹”、“COVID-19后疫苗”、“COVID-19后皮肤表现”为关键词进行文献复习。方法:在Google Scholar、Scopus、PubMed、Web of Science数据库中进行检索。结果:我们查阅了241篇已发表的关于COVID-19后皮肤病学表现的研究,包括英国文献中COVID-19疫苗后带状疱疹再激活的研究和德国文献中的1例研究。我们的病例和文献中报道的其他4例患者年龄在20岁及以下。结论:水痘带状疱疹病毒属于疱疹病毒科,其特点是能够逃避宿主免疫系统并在神经节神经元中潜伏。感染的再次激活将导致带状疱疹,表现为皮肤分布的疼痛小泡。可能的联系是新型冠状病毒疫苗等以mrna为基础的疫苗抑制了1型干扰素。然而,潜在的相关性仍有待证明。
{"title":"Herpes Zoster Virus Reactivation in a 16 Year Old Female Post COVID-19 Vaccine. Case report and Review of the Literature.","authors":"Sadan Alharbi,&nbsp;Mohammed Alsubaie,&nbsp;Remah Alzayyat,&nbsp;Batool Alattas,&nbsp;Hassan AlAhmadi,&nbsp;Hanoof Alabdullatif","doi":"10.5455/medarh.2023.77.146-149","DOIUrl":"https://doi.org/10.5455/medarh.2023.77.146-149","url":null,"abstract":"<p><strong>Background: </strong>According to WHO, there have been 9205 fatal COVID-19 cases confirmed in Saudi Arabia out of 793,729 cases overall (5). During the development of COVID-19 vaccines, several technologies were used including DNA-based, RNA-based vaccines, non-replicating viral vector vaccines, and inactivated vaccines.</p><p><strong>Objective: </strong>We present a case of varicella zoster virus reactivation post COVID-19 vaccine in a young medically free 16 years old female and review of the literature using the keywords \"Herpes Zoster, \"varicella zoster\",\" shingles\", \"post COVID-19 vaccine\", \"Post COVID-19 cutaneous manifestations\".</p><p><strong>Methods: </strong>The search was conducted in Google Scholar, Scopus, PubMed, and Web of Science data bases.</p><p><strong>Results: </strong>We encountered 241 published studies in regard to post COVID-19 dermatologic manifestations including post COVID-19 vaccine herpes zoster reactivation in the English literature and one case in German. Our case and 4 other reported cases in the literature are patients aged of 20 years old and below.</p><p><strong>Conclusion: </strong>Varicella zoster virus falls under the family of Herpesviridae, It's characterized by its ability to escape host immune system and remain dormant in ganglionic neurons. Reactivation of the infection will result in herpes zoster manifesting as painful vesicles in a dermatomal distribution. Possible link is the suppression of type-one interferons caused by the mRNA-based vaccine such as COVID-19 vaccines. Yet, potential correlation remains to be demonstrated.</p>","PeriodicalId":18421,"journal":{"name":"Medicinski arhiv","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5f/39/medarch-77-146.PMC10227837.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9571263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Perceptions and Expectations of the Clinical Learning Environment in Saudi Arabia: a Multidisciplinary Study. 感知和期望的临床学习环境在沙特阿拉伯:一项多学科研究。
Q2 Medicine Pub Date : 2023-04-01 DOI: 10.5455/medarh.2023.77.132-136
Talal AlShammari, Saeed Alqahtani, Mohammed Al Jumaan, Rana Alameri, Cameron Gosling, Bronwyn Beovich, Brett Williams, Samer Al Haliq, Mohamed Kandil

Background: The clinical learning environment is a fundamental component of healthcare education. In this setting, students can develop the skills and knowledge necessary to become competent and efficient healthcare practitioners. Due to the importance of clinically based education, it is crucial to have a valid and reliable tool to enable its evaluation.

Objective: The aim of this study was to use the Clinical Learning Environment Inventory (CLEI) to examine the perceptions of Saudi undergraduate healthcare students regarding their actual and preferred clinical learning environment and explore the differences between the two viewpoints.

Methods: A cross-sectional survey design was utilised with a cohort of Saudi undergraduate healthcare students. Data regarding perceptions of the 'actual' and 'preferred' clinical learning environments were gathered with the Clinical Learning Environment Inventory tool.

Results: A total of 194 students participated and nine healthcare disciplines were represented. The highest mean score for both 'actual' and 'preferred' clinical learning environment was for the subscale Task Orientation. Significant differences between 'actual' and 'preferred' environments were demonstrated for Innovation and Individualization, with both subscales scoring higher for the 'preferred' environment. All five subscales-Individualization, Innovation, Involvement, Personalization, and Task Orientation-appear to be important aspects contributing to student satisfaction with their clinical learning environment.

Conclusion: Saudi healthcare students demonstrate a preference for a clinical learning environment with the utilization of new and interesting experiences, as well as recognition and accommodation of student individuality. Additionally, student satisfaction appears to be multifactorial in origin. Therefore, there may be many avenues available to enhance the clinical experiences of healthcare students, which is vitally important for the optimization of clinical learning opportunities.

背景:临床学习环境是卫生保健教育的基本组成部分。在这种情况下,学生可以发展必要的技能和知识,成为有能力和高效的医疗从业人员。由于临床教育的重要性,有一个有效和可靠的工具来评估是至关重要的。目的:本研究的目的是使用临床学习环境量表(CLEI)来检查沙特本科医疗保健学生对其实际和首选临床学习环境的看法,并探讨两种观点之间的差异。方法:采用横断面调查设计,对沙特本科生进行队列调查。关于“实际”和“首选”临床学习环境的感知数据通过临床学习环境清单工具收集。结果:共有194名学生参加,涉及9个卫生保健学科。“实际”和“首选”临床学习环境的平均得分最高的是任务取向子量表。创新和个性化的“实际”和“首选”环境之间存在显著差异,“首选”环境的两个子量表得分都较高。所有五个子量表——个性化、创新、参与、个性化和任务导向——似乎都是影响学生对临床学习环境满意度的重要方面。结论:沙特卫生保健专业的学生表现出对临床学习环境的偏好,利用新的和有趣的经验,以及对学生个性的认可和适应。此外,学生满意度似乎是多因素的起源。因此,可能有许多途径可以增强医疗保健学生的临床经验,这对于优化临床学习机会至关重要。
{"title":"The Perceptions and Expectations of the Clinical Learning Environment in Saudi Arabia: a Multidisciplinary Study.","authors":"Talal AlShammari,&nbsp;Saeed Alqahtani,&nbsp;Mohammed Al Jumaan,&nbsp;Rana Alameri,&nbsp;Cameron Gosling,&nbsp;Bronwyn Beovich,&nbsp;Brett Williams,&nbsp;Samer Al Haliq,&nbsp;Mohamed Kandil","doi":"10.5455/medarh.2023.77.132-136","DOIUrl":"https://doi.org/10.5455/medarh.2023.77.132-136","url":null,"abstract":"<p><strong>Background: </strong>The clinical learning environment is a fundamental component of healthcare education. In this setting, students can develop the skills and knowledge necessary to become competent and efficient healthcare practitioners. Due to the importance of clinically based education, it is crucial to have a valid and reliable tool to enable its evaluation.</p><p><strong>Objective: </strong>The aim of this study was to use the Clinical Learning Environment Inventory (CLEI) to examine the perceptions of Saudi undergraduate healthcare students regarding their actual and preferred clinical learning environment and explore the differences between the two viewpoints.</p><p><strong>Methods: </strong>A cross-sectional survey design was utilised with a cohort of Saudi undergraduate healthcare students. Data regarding perceptions of the 'actual' and 'preferred' clinical learning environments were gathered with the Clinical Learning Environment Inventory tool.</p><p><strong>Results: </strong>A total of 194 students participated and nine healthcare disciplines were represented. The highest mean score for both 'actual' and 'preferred' clinical learning environment was for the subscale Task Orientation. Significant differences between 'actual' and 'preferred' environments were demonstrated for Innovation and Individualization, with both subscales scoring higher for the 'preferred' environment. All five subscales-Individualization, Innovation, Involvement, Personalization, and Task Orientation-appear to be important aspects contributing to student satisfaction with their clinical learning environment.</p><p><strong>Conclusion: </strong>Saudi healthcare students demonstrate a preference for a clinical learning environment with the utilization of new and interesting experiences, as well as recognition and accommodation of student individuality. Additionally, student satisfaction appears to be multifactorial in origin. Therefore, there may be many avenues available to enhance the clinical experiences of healthcare students, which is vitally important for the optimization of clinical learning opportunities.</p>","PeriodicalId":18421,"journal":{"name":"Medicinski arhiv","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a1/d5/medarch-77-132.PMC10227838.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9571264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association Between Serum Cytotoxic T Lymphocyte Antigen (CTLA)-4 Level and Disease Progression in Patients With Chronic Hepatitis B. 慢性乙型肝炎患者血清细胞毒性T淋巴细胞抗原(CTLA)-4水平与疾病进展的关系
Q2 Medicine Pub Date : 2023-04-01 DOI: 10.5455/medarh.2023.77.142-145
Darmadi Darmadi, Dharma Lindarto, Jelita Siregar, Tri Widyawati, Muhammad Rusda, Mustafa Mahmud Amin, Fauzi Yusuf, Putri Chairani Eyanoer, Masrul Lubis, Imelda Rey

Backgroud: Immune impairment, marked by increased expression of cytotoxic T lymphocyte antigen (CTLA)-4, promotes the disease progression of chronic hepatitis B.

Objective: This study aimed to determine the association between serum CTLA-4 level and disease progression in patients with chronic hepatitis B.

Methods: A cross-sectional study was conducted at Haji Adam Malik General Hospital Medan, Indonesia between October 2021 to September 2022. A total of 150 participants were enrolled. Patients aged 18 years or older with evidence of chronic hepatitis B, HBV-related liver cirrhosis, and HBV-related hepatocellular carcinoma (HCC) were enrolled. Exclusion criteria were history of chronic hepatotoxic drug consumption, underlying liver abnormalities other than HBV infection, and liver injury due to metastasized malignancy from other sites. Serum CTLA-4 level was determined from serum using human CTLA-4 enzyme linked immunosorbent assay kit.

Results: Most participants were males and aged between 40 and 60 years. Serum CTLA-4 level was positively associated with chronic hepatitis B progression (P<0.001). Serum CTLA-4 level was negatively correlated with serum platelet (P<0.001) and albumin levels (P<0.001) but positively correlated with serum ALT (P=0.045) and total bilirubin levels (P<0.001).

Conclusions: Serum CTLA-4 level is associated with disease progression in patients with chronic hepatitis B.

背景:以细胞毒性T淋巴细胞抗原(CTLA)-4表达增加为标志的免疫功能障碍促进慢性乙型肝炎的疾病进展。目的:本研究旨在确定慢性乙型肝炎患者血清CTLA-4水平与疾病进展之间的关系。方法:2021年10月至2022年9月在印度尼西亚棉兰Haji Adam Malik总医院进行横切性研究。总共有150名参与者被招募。年龄在18岁或以上且有慢性乙型肝炎、hbv相关肝硬化和hbv相关肝细胞癌(HCC)证据的患者被纳入研究。排除标准为慢性肝毒性药物使用史,HBV感染以外的潜在肝脏异常,以及其他部位恶性肿瘤转移引起的肝损伤。采用人CTLA-4酶联免疫吸附测定试剂盒测定血清CTLA-4水平。结果:大多数参与者为男性,年龄在40至60岁之间。血清CTLA-4水平与慢性乙型肝炎进展呈正相关(p结论:血清CTLA-4水平与慢性乙型肝炎患者疾病进展相关。
{"title":"Association Between Serum Cytotoxic T Lymphocyte Antigen (CTLA)-4 Level and Disease Progression in Patients With Chronic Hepatitis B.","authors":"Darmadi Darmadi,&nbsp;Dharma Lindarto,&nbsp;Jelita Siregar,&nbsp;Tri Widyawati,&nbsp;Muhammad Rusda,&nbsp;Mustafa Mahmud Amin,&nbsp;Fauzi Yusuf,&nbsp;Putri Chairani Eyanoer,&nbsp;Masrul Lubis,&nbsp;Imelda Rey","doi":"10.5455/medarh.2023.77.142-145","DOIUrl":"https://doi.org/10.5455/medarh.2023.77.142-145","url":null,"abstract":"<p><strong>Backgroud: </strong>Immune impairment, marked by increased expression of cytotoxic T lymphocyte antigen (CTLA)-4, promotes the disease progression of chronic hepatitis B.</p><p><strong>Objective: </strong>This study aimed to determine the association between serum CTLA-4 level and disease progression in patients with chronic hepatitis B.</p><p><strong>Methods: </strong>A cross-sectional study was conducted at Haji Adam Malik General Hospital Medan, Indonesia between October 2021 to September 2022. A total of 150 participants were enrolled. Patients aged 18 years or older with evidence of chronic hepatitis B, HBV-related liver cirrhosis, and HBV-related hepatocellular carcinoma (HCC) were enrolled. Exclusion criteria were history of chronic hepatotoxic drug consumption, underlying liver abnormalities other than HBV infection, and liver injury due to metastasized malignancy from other sites. Serum CTLA-4 level was determined from serum using human CTLA-4 enzyme linked immunosorbent assay kit.</p><p><strong>Results: </strong>Most participants were males and aged between 40 and 60 years. Serum CTLA-4 level was positively associated with chronic hepatitis B progression (P<0.001). Serum CTLA-4 level was negatively correlated with serum platelet (P<0.001) and albumin levels (P<0.001) but positively correlated with serum ALT (P=0.045) and total bilirubin levels (P<0.001).</p><p><strong>Conclusions: </strong>Serum CTLA-4 level is associated with disease progression in patients with chronic hepatitis B.</p>","PeriodicalId":18421,"journal":{"name":"Medicinski arhiv","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/fb/65/medarch-77-142.PMC10227835.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9573230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Differences Interval Training and Continuous Training on Endorphin Level and Anxiety Degrees in SECABA Rindam III Siliwangi Student Soldiers with Moderate Anxiety. 间歇训练与持续训练对中度焦虑的SECABA Rindam III西里旺吉学生兵内啡肽水平和焦虑程度的影响
Q2 Medicine Pub Date : 2023-04-01 DOI: 10.5455/medarh.2023.77.127-131
Lidwina Marlina, Ambrosius Purba, Veranita Pandia, Maya Rosmawati Adiwinata, Novita Sari Harahap, Daniel Womsiwor

Background: Endorphin is a biological change in molecular physiology that is commonly connected with anxiety. An increase in the level of anxiety is caused by both an increase and a decrease in the number of endorphins that are present in the brain; however, up until this point, it has never been reported that there is a relationship between the level of anxiety and the influence of interval training.

Objective: The purpose of this study was to analyze the effect of training interval on endorphin level and anxiety degrees of secaba student soldiers with moderate degrees of anxiety.

Methods: The subject of the study was a student soldier of Secaba Rindam III Siliwangi with moderate anxiety. The subject of the study gets information about the objectives and procedures of the study. Subjects who are willing to participate in the study sign informed consent. The next step was that group 1 was given an interval training treatment 3 times a week for 12 weeks and group 2 was given continuous training treatment.

Results: The results showed that there was a difference where interval training is better than continuous training against increasing endorphin levels (30.9111.733 vs. 39.6519.956; p=0.043). The degree of anxiety decreased significantly after being given interval training treatment (64.64±3.671 vs. 29.50±4.165; p=0.0001). Similarly, there was a significant difference (p=0.027; p<0.05) where the treatment in the interval training group was better than that of the continuous training group against a decrease in the degree of anxiety.

Conclusion: Interval training can increase endorphin levels in Secaba Rindam III Siliwangi Student Soldiers with Moderate Anxiety and Interval Training can lower the Degree of Anxiety in Secaba Rindam III Siliwangi Student Soldiers with Moderate Anxiety.

背景:内啡肽是分子生理学中的一种生物学变化,通常与焦虑有关。焦虑程度的增加是由大脑中内啡肽数量的增加和减少引起的;然而,到目前为止,还没有报道焦虑水平和间歇训练的影响之间存在关系。目的:分析训练间隔时间对中度焦虑的赛卡巴学生兵内啡肽水平和焦虑程度的影响。方法:研究对象为中度焦虑的西卡利旺吉军校学生兵。研究对象获得有关研究目的和程序的信息。愿意参加研究的受试者签署知情同意书。第1组进行间歇训练,每周3次,连续训练12周;第2组进行连续训练。结果:间歇训练对内啡肽水平升高的影响优于连续训练(30.9111.733 vs. 39.6519.956;p = 0.043)。间歇训练治疗后焦虑程度显著降低(64.64±3.671∶29.50±4.165;p = 0.0001)。同样,两组间差异有统计学意义(p=0.027;结论:间歇训练可提高中度焦虑赛卡巴林丹三期西里万吉学生兵内啡肽水平,间歇训练可降低中度焦虑赛卡巴林丹三期西里万吉学生兵的焦虑程度。
{"title":"Differences Interval Training and Continuous Training on Endorphin Level and Anxiety Degrees in SECABA Rindam III Siliwangi Student Soldiers with Moderate Anxiety.","authors":"Lidwina Marlina,&nbsp;Ambrosius Purba,&nbsp;Veranita Pandia,&nbsp;Maya Rosmawati Adiwinata,&nbsp;Novita Sari Harahap,&nbsp;Daniel Womsiwor","doi":"10.5455/medarh.2023.77.127-131","DOIUrl":"https://doi.org/10.5455/medarh.2023.77.127-131","url":null,"abstract":"<p><strong>Background: </strong>Endorphin is a biological change in molecular physiology that is commonly connected with anxiety. An increase in the level of anxiety is caused by both an increase and a decrease in the number of endorphins that are present in the brain; however, up until this point, it has never been reported that there is a relationship between the level of anxiety and the influence of interval training.</p><p><strong>Objective: </strong>The purpose of this study was to analyze the effect of training interval on endorphin level and anxiety degrees of secaba student soldiers with moderate degrees of anxiety.</p><p><strong>Methods: </strong>The subject of the study was a student soldier of Secaba Rindam III Siliwangi with moderate anxiety. The subject of the study gets information about the objectives and procedures of the study. Subjects who are willing to participate in the study sign informed consent. The next step was that group 1 was given an interval training treatment 3 times a week for 12 weeks and group 2 was given continuous training treatment.</p><p><strong>Results: </strong>The results showed that there was a difference where interval training is better than continuous training against increasing endorphin levels (30.9111.733 vs. 39.6519.956; p=0.043). The degree of anxiety decreased significantly after being given interval training treatment (64.64±3.671 vs. 29.50±4.165; p=0.0001). Similarly, there was a significant difference (p=0.027; p<0.05) where the treatment in the interval training group was better than that of the continuous training group against a decrease in the degree of anxiety.</p><p><strong>Conclusion: </strong>Interval training can increase endorphin levels in Secaba Rindam III Siliwangi Student Soldiers with Moderate Anxiety and Interval Training can lower the Degree of Anxiety in Secaba Rindam III Siliwangi Student Soldiers with Moderate Anxiety.</p>","PeriodicalId":18421,"journal":{"name":"Medicinski arhiv","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/da/9a/medarch-77-127.PMC10227839.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9573233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Medicinski arhiv
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1